"Clinical Research Trials"

During the past decade, Neuro-Behavioral Clinical Research, Inc. conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 38 clinical trials were completed, i.e. on average, 73.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 26 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neuro-Behavioral Clinical Research, Inc." #1 sponsor was "Indivior Inc." with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Astellas Pharma Global Development, Inc." with 3 trials sponsored, "Forest Laboratories" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neuro-Behavioral Clinical Research, Inc." #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "ClinEdge, LLC" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Neuro-Behavioral Clinical Research, Inc." are "Major Depressive Disorder" (9 trials), "Schizophrenia" (8 trials), "Alzheimer's Disease" (7 trials), "Depressive Disorder, Major" (7 trials) and "Alzheimer Disease" (6 trials). Many other conditions were trialed in "Neuro-Behavioral Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Neuro-Behavioral Clinical Research, Inc." are "Drug" (64 trials), "Other" (6 trials), "Device" (3 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "RBP-6000" (3 trials), "Rapastinel" (3 trials), "Xanomeline and Trospium Chloride Capsules" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Neuro-Behavioral Clinical Research, Inc." are 69 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Neuro-Behavioral Clinical Research, Inc.". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in Neuro-Behavioral Clinical Research, Inc., undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Neuro-Behavioral Clinical Research, Inc., 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".